Interpretation of the first international consensus for Cornelia de Lange syndrome
ZHOU Ping1, ZHU Lin1, FAN Qiong-Li2, CHEN Li1
Growth, Development and Mental Health Center for Child and Adolescent, Children's Hospital of Chongqing Medical University/National Clinical Research Center for Child Health and Disorders/Ministry of Education Key Laboratory of Child Development and Disorders/China International Science and Technology Cooperation Base of Child Development and Critical Disorders/Chongqing Key Laboratory of Child Health and Nutrition, Chongqing 400014, China
Cornelia de Lange综合征（CdLS）是一种以严重神经发育障碍为主要表现的遗传综合征，临床表现为智力障碍、典型的面部特征、宫内和生后生长发育迟缓及多器官系统畸形等，发病率约1/10?000~1/30?000。2017年国际CdLS共识小组成立，并于2018年7月发表了国际上首个关于CdLS的共识“Diagnosis and management of Cornelia de Lange syndrome：first international consensus statement”（《Cornelia de Lange综合征的诊断和管理：第一份国际共识声明》）。该共识通过改良德尔菲法制定，对CdLS患儿的诊断和管理提出了若干指导性意见。该文对共识进行解读，旨在帮助临床医生早期识别、诊断、规范随访及管理CdLS患者。
Abstract：Cornelia de Lange syndrome (CdLS) is a genetic syndrome with severe neurodevelopmental disorders as the main manifestation. Its clinical manifestations included mental retardation, typical facial features, intrauterine and postnatal developmental delay, and deformity in multiple organs and systems, with an incidence rate of about 1/10 000 to 1/30 000. International CdLS Consensus Group was established in 2017 and issued the first international consensus on CdLS, i.e., "Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement", in July 2018. Being developed through a modified Delphi consensus process, this consensus provides guidance on the diagnosis and management of children with CdLS. This article gives an interpretation of this consensus, aiming to help clinicians with early identification, diagnosis, standard follow-up, and management of this disease.
周平,朱琳,范琼丽等. Cornelia de Lange综合征首个国际共识的解读[J]. 中国当代儿科杂志, 2020, 22(8): 815-820.
ZHOU Ping,ZHU Lin,FAN Qiong-Li et al. Interpretation of the first international consensus for Cornelia de Lange syndrome[J]. CJCP, 2020, 22(8): 815-820.
Bottai D, Spreafico M, Pistocchi A, et al. Modeling Cornelia de Lange syndrome in vitro and in vivo reveals a role for cohesin complex in neuronal survival and differentiation[J]. Hum Mol Genet, 2019, 28(1):64-73.
[2]
Kline AD, Moss JF, Selicorni A, et al. Diagnosis and management of Cornelia de Lange syndrome:first international consensus statement[J]. Nat Rev Genet, 2018, 19(10):649-666.
[3]
Olley G, Ansari M, Bengani H, et al. BRD4 interacts with NIPBL and BRD4 is mutated in a Cornelia de Lange-like syndrome[J]. Nat Genet, 2018, 50(3):329-332.
[4]
Allanson JE, Hennekam RC, Ireland M. De Lange syndrome:subjective and objective comparison of the classical and mild phenotypes[J]. J Med Genet, 1997, 34(8):645-650.
[5]
Kline AD, Grados M, Sponseller P, et al. Natural history of aging in Cornelia de Lange syndrome[J]. Am J Med Genet C Semin Med Genet, 2007, 145C(3):248-260.
[6]
Kaur M, Mehta D, Noon SE, et al. NIPBL expression levels in CdLS probands as a predictor of mutation type and phenotypic severity[J]. Am J Med Genet C Semin Med Genet, 2016, 172(2):163-170.
[7]
Kline AD, Krantz ID, Sommer A, et al. Cornelia de Lange syndrome:clinical review, diagnostic and scoring systems, and anticipatory guidance[J]. Am J Med Genet A, 2007, 143A(12):1287-1296.
[8]
Boyle MI, Jespersgaard C, Brøndum-Nielsen K, et al. Cornelia de Lange syndrome[J]. Clin Genet, 2015, 88(1):1-12.
[9]
Clark DM, Sherer I, Deardorff MA, et al. Identification of a prenatal profile of Cornelia de Lange syndrome (CdLS):a review of 53 CdLS pregnancies[J]. Am J Med Genet A, 2012, 158A(8):1848-1856.
[10]
Avagliano L, Bulfamante GP, Massa V. Cornelia de Lange syndrome:to diagnose or not to diagnose in utero?[J]. Birth Defects Res, 2017, 109(10):771-777.
[11]
Wilmink FA, Papatsonis DN, Grijseels EW, et al. Cornelia de Lange syndrome:a recognizable fetal phenotype[J]. Fetal Diagn Ther, 2009, 26(1):50-53.
[12]
Braunholz D, Obieglo C, Parenti I, et al. Hidden mutations in Cornelia de Lange syndrome limitations of sanger sequencing in molecular diagnostics[J]. Hum Mutat, 2015, 36(1):26-29.
[13]
Schrier SA, Sherer I, Deardorff MA, et al. Causes of death and autopsy findings in a large study cohort of individuals with Cornelia de Lange syndrome and review of the literature[J]. Am J Med Genet A, 2011, 155A(12):3007-3024.
[14]
Clermidi P, Abadie V, Campeotto F, et al. Sigmoid volvulus:an underestimated cause of intestinal obstruction in Cornelia de Lange syndrome[J]. J Pediatr, 2015, 167(4):941-941.e1.
[15]
Wierzba J, Mazurkiewicz-Bełdzińska M, Jabłońska-Brudło J, et al. Challenges of caring for a patient with a rare disease-as demonstrated by Cornelia de Lange syndrome[J]. Dev Period Med, 2015, 19(4):511-515.
